1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
699E5BE46B633852A652580A7001BF717
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-healthcare-digital-marketing-innovation-staffing-budget-future-trends?opendocument
18
19opendocument
2034.228.38.35
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Digital Marketing

Healthcare Digital Marketing Innovation: Staffing, Budget and Future Trends

ID: 5445


Features:

6 Info Graphics

20 Data Graphics

280+ Metrics


Pages/Slides: 33


Published: 2017


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from Healthcare Digital Marketing Innovation: Staffing, Budget and Future Trends”

STUDY OVERVIEW

With digital marketing innovation both inside and outside the pharma industry transforming the way the industry engages with physicians and patients, pharma companies are increasingly investing in digital marketing. To maximize performance, digital leaders must have appropriate resources to ensure effective digital marketing initiatives, channels, and tools.

Best Practices, LLC undertook benchmarking research to probe how savvy biopharma digital marketers are right-sizing budget and staffing investment levels and seizing digital health opportunities for maximum impact. The study also identifies the top challenges to the growth and long-term success of the digital marketing function.

Insights in this study are segmented by: Company Size – Large Companies and Medium and Small Companies, Team - Global Teams and U.S. Only Teams.

KEY TOPICS


I. Optimizing Digital Investment:
  • Staffing levels
  • Budget allocation

II. Future Direction:
  • Top challenges
  • Digital health opportunities

KEY METRICS

  • Organization’s Total FTE Staffing Investment for All Internal Employees Working on Digital Marketing
  • Organization’s Total FTE Staffing Investment for All External Contractors and Consultants Working on Digital Marketing
  • Organization’s Total FTE Staffing Investment for All of Digital Marketing
  • Digital Marketing Budget Allocation
  • Percentage of Organization's Total Marketing Budget Allocated Specifically to Digital Marketing Activities and Programs
  • Significant Challenges to the Growth and Long-Term Success of the Digital Marketing Function
  • How are Participants Integrating Digital Health Opportunities into their Digital Marketing Operations?

SAMPLE KEY FINDINGS

  • Large companies lead the way in cross-industry digital collaboration: Close to three-fourths of large companies are partnering with technology firms to create new platforms and tools to derive better insights and improve health outcomes. More than half of these large companies are also acquiring startups and existing assets, investing in mobile, and exploring the use of wearable devices. In contrast, the vast majority of medium and smaller companies are addressing digital health opportunities simply by hiring new personnel.

METHODOLOGY

Best Practices, LLC engaged 31 digital, multichannel marketing and other commercial leaders from 24 leading healthcare organizations through a benchmarking survey instrument. Nearly 70% of participants serve at the level of director or above.


Industries Profiled:
Biopharmaceutical; Pharmaceutical; Medical Device; Manufacturing; Biotech; Consumer Products; Diagnostic; Health Care; Chemical; Consulting; Education


Companies Profiled:
Alkermes; Astellas; Baxter International; Bayer; CSL Behring; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline ; Insyght; Integra LifeSciences; MediMedia; Merck; Mylan; Nektar Therapeutics; Novartis; Pfizer; Precision For Value; Prometheus Therapeutics & Diagnostics; Roche; Shionogi Inc.; Sunovion; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.